Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries
Authors:
- Hege Salvesen BlixHBHege Salvesen Blix
- Diamantis PlachourasDPDiamantis Plachouras
- the European Survey on Transatlantic Task Force on Antimicrobial Resistance (TATFAR) action 1.2 groupTGthe European Survey on Transatlantic Task Force on Antimicrobial Resistance (TATFAR) action 1.2 group
Open Access
- 11 July 2019
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 24 (28) , 2-12
Abstract
Unnecessary and inappropriate use of antibiotics in human healthcare is a major driver for the development and spread of antimicrobial resistance; many countries are implementing measures to limit the overuse and misuse of antibiotics e.g. through the establishment of antimicrobial use reduction targets. We performed a review of antimicrobial use reduction goals in human medicine in Transatlantic Taskforce on Antimicrobial Resistance partner countries. On 31 March 2017, the European Centre for Disease Prevention and Control sent a questionnaire to National Focal Points for Antimicrobial Consumption and the National Focal Points for Antimicrobial Resistance in 28 European Union countries, Iceland and Norway. The same questionnaire was sent to the TATFAR implementers in Canada and the United States. Thirty of 32 countries replied. Only nine countries indicated that they have established targets to reduce antimicrobial use in humans. Twenty-one countries replied that no target had been established. However, 17 of these 21 countries indicated that work to establish such targets is currently underway, often in the context of developing a national action plan against antimicrobial resistance. The reported targets varied greatly between countries and can be a useful resource for countries willing to engage in the reduction of antibiotic use in humans.Keywords
This publication has 10 references indexed in Scilit:
- Potential for reducing inappropriate antibiotic prescribing in English primary careJournal of Antimicrobial Chemotherapy, 2018
- ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional surveyJournal of Antimicrobial Chemotherapy, 2017
- Antibiotic prescribing during office hours and out-of-hours: a comparison of quality and quantity in primary care in the NetherlandsBritish Journal of General Practice, 2017
- Antibiotic management of children with infectious diseases in Dutch Primary CareFamily Practice, 2017
- Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, the Netherlands and Sweden: use of European quality indicatorsScandinavian Journal of Primary Health Care, 2017
- Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your FingertipsJournal of Antimicrobial Chemotherapy, 2016
- Frequency of First-line Antibiotic Selection Among US Ambulatory Care Visits for Otitis Media, Sinusitis, and PharyngitisJAMA Internal Medicine, 2016
- Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003–2010Eurosurveillance, 2016
- Improving antibiotic prescribing quality by an intervention embedded in the primary care practice accreditation: the ARTI4 randomized trialJournal of Antimicrobial Chemotherapy, 2015
- Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choicesScandinavian Journal of Infectious Diseases, 2008